Literature DB >> 28207610

Choroidal Neovascularization.

Richard F Spaide1.   

Abstract

Mesh：

Substances：

Year:  2017        PMID： 28207610     DOI： 10.1097/IAE.0000000000001575

Source DB:  PubMed          Journal:  Retina        ISSN： 0275-004X            Impact factor:   4.256


× No keyword cloud information.
  10 in total

1.  Clinical characteristics and visual outcomes of non-resolving subretinal fluid in neovascular AMD despite continuous monthly anti-VEGF injections: a long-term follow-up.

Authors:  Hamid Hosseini; Gilad Rabina; Moritz Pettenkofer; Adrian Au; Ismael Chehaibou; Gad Heilweil; Adam J Weiner; Michael Ip; Anat Loewenstein; Steven D Schwartz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-11-27       Impact factor: 3.117

2.  Optical Coherence Tomography Angiography to Distinguish Changes of Choroidal Neovascularization after Anti-VEGF Therapy: Monthly Loading Dose versus Pro Re Nata Regimen.

Authors:  Alexandra Miere; Hassiba Oubraham; Francesca Amoroso; Pauline Butori; Polina Astroz; Oudy Semoun; Elsa Bruyere; Alexandre Pedinielli; Manar Addou-Regnard; Camille Jung; Salomon Y Cohen; Eric H Souied
Journal:  J Ophthalmol       Date:  2018-02-04       Impact factor: 1.909

3.  Relationship between Neovascular Density in Swept Source-Optical Coherence Tomography Angiography and Signs of Activity in Exudative Age-Related Macular Degeneration.

Authors:  Martin Stattin; Julia Forster; Ahmed Daniel; Alexandra Graf; Katharina Krepler; Siamak Ansari-Shahrezaei
Journal:  J Ophthalmol       Date:  2019-07-09       Impact factor: 1.909

4.  Swept Source-Optical Coherence Tomography Angiography for Management of Secondary Choroidal Neovascularization in Punctate Inner Choroidopathy.

Authors:  Martin Stattin; Julia Forster; Daniel Ahmed; Katharina Krepler; Siamak Ansari-Shahrezaei
Journal:  Case Rep Ophthalmol       Date:  2021-04-12

5.  Safety and Tolerability of Intravitreal Carotuximab (DE-122) in Patients With Persistent Exudative Age-Related Macular Degeneration: A Phase I Study.

Authors:  Victor H Gonzalez; Brian Berger; Roger Goldberg; Carmelina M Gordon; Rahul N Khurana; Raymund Angeles; Naveed Shams
Journal:  Transl Vis Sci Technol       Date:  2021-12-01       Impact factor: 3.283

6.  Choroidal Neovascularization in Pediatric Patients: Analysis of Etiologic Factors, Clinical Characteristics and Treatment Outcomes.

Authors:  Ting Zhang; You Wang; Wenjia Yan; Yafen Liu; Jinglin Lu; Limei Sun; Songshan Li; Li Huang; Zhaotian Zhang; Xiaoyan Ding
Journal:  Front Med (Lausanne)       Date:  2021-11-29

7.  Short-term anatomic response of the choroid to tropicamide in myopic patients.

Authors:  Chih-Ying Lin; I Wang; Chun-Ju Lin; Chun-Ting Lai; Henry Bair; Wen-Lu Chen; Jane-Ming Lin; Peng-Tai Tien; Ning-Yi Hsia; Yi-Yu Tsai
Journal:  Medicine (Baltimore)       Date:  2022-09-16       Impact factor: 1.817

8.  Quantitative optical coherence tomography angiography biomarkers for neovascular age-related macular degeneration in remission.

Authors:  Florence Coscas; Diogo Cabral; Telmo Pereira; Carlos Geraldes; Hemaxi Narotamo; Alexandra Miere; Marco Lupidi; Alexandre Sellam; Ana Papoila; Gabriel Coscas; Eric Souied
Journal:  PLoS One       Date:  2018-10-09       Impact factor: 3.240

9.  Evaluation of efficacy and recurrence for anti-vascular endothelial growth factor therapy in idiopathic choroidal neovascularization.

Authors:  Qianru Wu; Xiaoyong Chen; Kang Feng; Yuling Liu; Chun Zhang; Lin Zhao
Journal:  BMC Ophthalmol       Date:  2020-03-19       Impact factor: 2.209

10.  Spectral domain-optical coherence tomography retinal biomarkers in choroidal neovascularization of multifocal choroiditis, myopic choroidal neovascularization, and idiopathic choroidal neovascularization.

Authors:  Rui Gao; Jingxue Ma; Zhengwei Zhang; Qingli Shang; Jialiang Duan
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.